HCMT
AVDL

Highland Capital Management (Texas)’s Avadel Pharmaceuticals AVDL Stock Holding History

Highland Capital Management (Texas)’s Portfolio AVDL Stock Details AVDL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q1 		– Sell
-99,500
Closed -$1.7M – 225
2014
Q4 		$1.7M Buy
+99,500
New +$1.42M 0.06% 141

Other funds holding AVDL

BC
Broadfin Capital New York $747M AUM 100.56% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
JHIU
Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
KCM
Kennedy Capital Management St Louis, Missouri $4.72B AUM 36.69% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
SCM
Sarissa Capital Management Greenwich, Connecticut $158M AUM 103.7% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return

Highland Capital Management (Texas)'s AVDL Position: Q1 2015 in Review

Highland Capital Management (Texas) sold out of Avadel Pharmaceuticals (AVDL) in Q1 2015, closing a stake of 99,500 shares — an estimated $1.7M sold.

Highland Capital Management (Texas) first reported a position in AVDL in Q4 2014 and held it in 1 quarter. The position peaked at $1.7M in Q4 2014. 84 funds tracked by Wall St. Rank hold AVDL as of Q1 2015.

  • Highland Capital Management (Texas) reported no remaining Avadel Pharmaceuticals position as of Q1 2015 after selling out during the quarter.
  • Highland Capital Management (Texas) sold 99,500 Avadel Pharmaceuticals shares in Q1 2015, an estimated $1.7M.
  • Highland Capital Management (Texas) first reported a position in Avadel Pharmaceuticals in Q4 2014 and held it in 1 quarter.
  • Highland Capital Management (Texas)'s Avadel Pharmaceuticals position peaked at $1.7M in Q4 2014.
  • 84 funds tracked by Wall St. Rank held Avadel Pharmaceuticals as of Q1 2015.

Based on Highland Capital Management (Texas)'s 13F filing for Q1 2015, filed 15 May 2015.